Head of the AIDS Center: lenacapavir trials showed great success
The drug “Lenacapavir” for effective protection against HIV requires two intramuscular injections per year
Scientists have tested a new drug, Lenacapavir, which protects against HIV. In tests, none of more than 2,000 women who received the virus became infected with it. The media reported on this.
“As part of the lenacapavir trials, none of the more than 2 thousand women who received it became infected, while cases of infection occurred in those who took the pills,” said RBC. They also said that the drug requires two intramuscular injections per year to protect a person from HIV.
The tack cited the words of the director of the Federal Methodological Center for AIDS Prevention and Control, Vadim Pokrovsky, who called the Lenacapavir trials “a great success”. He clarified that the originality of the drug lies in the fact that it is introduced into the body by injection. Previously, PrEP medications were only available in tablet form.
The expert also noted the cost of the drug: 40 thousand dollars for an annual course. According to him, in Russia the question will also arise: “who should use this drug and will the state pay for it.”
However, earlier the chief physician of the Nizhny Novgorod Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Solomon Apoyan, said that it is impossible to talk about the 100% effectiveness of Lenacapavir until clinical trials on men are completed. The expert also explained that as soon as the medicine starts to be bought en masse, its price will decrease. This happens with most drugs. Apoyan’s words are narrated by “National News Service».
Save the number URA.RU – be the first to report the news!
Signature of URA.RU on Telegram – a convenient way to keep up with important news! Subscribe and be in the middle of events. Subscribe.
Scientists have tested a new drug, Lenacapavir, which protects against HIV. In tests, none of more than 2,000 women who received the virus became infected with it. The media reported on this. “As part of the lenacapavir trials, none of the more than 2 thousand women who received it became infected, while cases of infection occurred in those who took the pills,” said RBC. They also said that the drug requires two intramuscular injections per year to protect a person from HIV. The tack cited the words of the director of the Federal Methodological Center for AIDS Prevention and Control, Vadim Pokrovsky, who called the Lenacapavir trials “a great success”. He clarified that the originality of the drug lies in the fact that it is introduced into the body by injection. Previously, PrEP medications were only available in tablet form. The expert also noted the cost of the drug: 40 thousand dollars for an annual course. According to him, in Russia the question will also arise: “who should use this drug and will the state pay for it.” However, earlier the chief physician of the Nizhny Novgorod Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Solomon Apoyan, said that it is impossible to talk about the 100% effectiveness of Lenacapavir until clinical trials on men are completed. The expert also explained that as soon as the medicine starts to be bought en masse, its price will decrease. This happens with most drugs. Apoyan’s words are reported by the National News Service.
#Doctors #tested #innovative #drug #protect #HIV
2024-08-05 02:49:00
